Health


 State Street Corp Increases Stake in Catalent, Inc. (NYSE:CTLT)

State Street Corp Increases Stake in Catalent, Inc. (NYSE:CTLT)

December 10, 2024 08:20 AM PST| By Team Kalkine Media

Highlights,State Street Corp increased its stake in Catalent by 1.5% in Q3.,Catalent reported a slight miss on earnings in its most recent quarter.,The company operates in the biologics and pharmaceutical manufacturing sectors.,Catalent Inc. continue...

 Protara Therapeutics Prices $100Mn Public Offering to Advance Cancer and Rare Disease Therapies

Protara Therapeutics Prices $100Mn Public Offering to Advance Cancer and Rare Disease Therapies

December 09, 2024 10:05 PM PST| By Team Kalkine Media

Highlights,Public Offering Details:,Protara is offering 13.69 million shares at $6.25 each and pre-funded warrants for 2.33 million shares at $6.249 each, totaling approximately $100 million in gross proceeds.,Use of Funds:,Proceeds will support clin...

 Nona Biosciences and Kodiak Sciences Partner to Advance Multi-Target Antibody Discovery for Ophthalmic Diseases

Nona Biosciences and Kodiak Sciences Partner to Advance Multi-Target Antibody Discovery for Ophthalmic Diseases

December 09, 2024 10:03 PM PST| By Team Kalkine Media

Highlights,Collaborative Innovation:,Nona Biosciences partners with Kodiak Sciences to develop novel multi-target antibodies targeting ophthalmic diseases.,Cutting-Edge Platform:,The collaboration utilizes Nona’s Harbour Mice® technology, offering fu...

 Arcellx Presents Positive Phase 2 Data for Anito-cel in Relapsed or Refractory Multiple Myeloma at ASH 2024

Arcellx Presents Positive Phase 2 Data for Anito-cel in Relapsed or Refractory Multiple Myeloma at ASH 2024

December 09, 2024 01:34 AM PST| By Team Kalkine Media

Highlights,High Response Rates:,The Phase 2 iMMagine-1 study of anito-cel in relapsed or refractory multiple myeloma (RRMM) patients showed an overall response rate (ORR) of 97%, with 62% achieving complete or stringent complete responses (CR/sCR).,D...

 Disc Medicine Announces Positive Phase 1b Data for DISC-0974 in Myelofibrosis and Anemia at ASH 2024

Disc Medicine Announces Positive Phase 1b Data for DISC-0974 in Myelofibrosis and Anemia at ASH 2024

December 09, 2024 01:30 AM PST| By Team Kalkine Media

Highlights,DISC-0974 demonstrates substantial reductions in hepcidin and increases in iron levels, leading to significant improvements in anemia across multiple patient types.,68% of non-transfusion dependent patients experienced a ≥1.5 g/dL increase...

 VolitionRx (NYSE:VNRX) Pioneering Epigenetic Diagnostics

VolitionRx (NYSE:VNRX) Pioneering Epigenetic Diagnostics

December 06, 2024 08:10 AM PST| By Team Kalkine Media

Highlights,Geode Capital Management increased its stake by 15.1%.,VolitionRx develops cutting-edge blood tests for early cancer detection.,Q tests cater to both human and veterinary markets.,VolitionRx Limited is advancing the field of epigenetics wi...

 Exploring Alaskan Gold with International Tower Hill Mines (NYSE:THM)

Exploring Alaskan Gold with International Tower Hill Mines (NYSE:THM)

December 06, 2024 08:10 AM PST| By Team Kalkine Media

Highlights,International Tower Hill Mines focuses on gold exploration in Alaska.,The company’s Livengood Gold Project is a key area of interest.,Shares have shown recent price fluctuations, with a 52-week range of $0.40 to $0.80.,International Tower...

 Annovis Bio's (NYSE:ANVS) Cash Burn and Financial Sustainability

Annovis Bio's (NYSE:ANVS) Cash Burn and Financial Sustainability

December 06, 2024 12:00 AM PST| By Team Kalkine Media

Highlights,Annovis Bio has a short cash runway of about 7 months.,The company reduced its cash burn by 33% in the past year.,Annovis Bio may face challenges raising funds without diluting shareholders.,Annovis Bio Inc, a biotechnology company, has be...

 UnitedHealth Group (NYSE:UNH) Dividend Outlook Stability and Growth

UnitedHealth Group (NYSE:UNH) Dividend Outlook Stability and Growth

December 05, 2024 09:50 AM PST| By Team Kalkine Media

Highlights,UnitedHealth Group announces a $2.10 per share dividend.,Payout ratio remains at 51% of earnings and 56% of free cash flow.,Company has increased dividends by 22% annually over the past decade.,UnitedHealth Group Incorporated is set to pay...

 Pfizer (NYSE:PFE) Gains Institutional Support and Strong Financials

Pfizer (NYSE:PFE) Gains Institutional Support and Strong Financials

December 05, 2024 09:40 AM PST| By Team Kalkine Media

Highlights,State Street Corp increases its position in Pfizer by 1.2%.,Pfizer’s revenue grew 31.2% year-over-year, reflecting strong performance.,Pfizer declares a dividend with an annualized yield of 6.66%.,Pfizer Inc. continues to attract strong in...

 Institutional Activity in Novo Nordisk A/S (NYSE:NVO) A Closer Look

Institutional Activity in Novo Nordisk A/S (NYSE:NVO) A Closer Look

December 05, 2024 09:35 AM PST| By Team Kalkine Media

Highlights,Quantinno Capital Management LP raised its stake in Novo Nordisk by 9.2% in Q3.,Institutional investors now hold 11.54% of Novo Nordisk’s shares.,Novo Nordisk focuses on Diabetes, Obesity Care.,Novo Nordisk A/S , a leader in the,NYSE Healt...

 CVS Health Co. (NYSE:CVS) Posts Strong Earnings Amid Stake Shifts

CVS Health Co. (NYSE:CVS) Posts Strong Earnings Amid Stake Shifts

December 05, 2024 09:20 AM PST| By Team Kalkine Media

Highlights,CVS Health Co. increases stake by 548.2%.,Institutional investors own 80.66% of CVS Health Co.,CVS Health Co. reports strong quarterly earnings and revenue growth.,CVS Health Corp. saw a significant increase in its stake among institutiona...

 Danaher Corp. (NYSE:DHR) Faces Analyst Scrutiny Amid Mixed Sentiment

Danaher Corp. (NYSE:DHR) Faces Analyst Scrutiny Amid Mixed Sentiment

December 05, 2024 09:15 AM PST| By Team Kalkine Media

Highlights,Diverse opinions from analysts on Danaher’s future.,Danaher’s stock shows fluctuations within a defined range.,Earnings beat expectations despite year-over-year declines.,Danaher Corporation, continues to generate mixed reactions from anal...

 Mesoblast (Nasdaq: MESO) Announces FDA RMAT Designation for Revascor® in Treatment of Hypoplastic Left Heart Syndrome

Mesoblast (Nasdaq: MESO) Announces FDA RMAT Designation for Revascor® in Treatment of Hypoplastic Left Heart Syndrome

December 05, 2024 12:45 AM PST| By Team Kalkine Media

Highlights,Mesoblast has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for its second-generation allogeneic stromal cell therapy Revascor® (rexlemestrocel-L) in treating children with Hypoplastic Left Heart Syndrome...

 McKesson Co. (NYSE:MCK) Steady Growth and Strong Institutional Backing

McKesson Co. (NYSE:MCK) Steady Growth and Strong Institutional Backing

December 04, 2024 08:40 AM PST| By Team Kalkine Media

Highlights,The Public Sector Pension Investment Board increased its holdings by 18.8%.,Mc Kesson shares performed well, with significant revenue growth in the latest quarter.,The company declared a quarterly dividend of $0.71 per share.,McKesson Corp...

 Institutional Backing Grows for Teladoc Health (NYSE:TDOC)

Institutional Backing Grows for Teladoc Health (NYSE:TDOC)

December 04, 2024 08:40 AM PST| By Team Kalkine Media

Highlights,Edgestream Partners L.P. acquired $1.83 million in Teladoc Health in Q3.,Teladoc Health's stock saw a series of analyst target price revisions.,Institutional investors control nearly 77% of Teladoc Health shares.,Teladoc Health, Inc, a lea...

 Novavax (NASDAQ: NVX) Sells Czech Manufacturing Facility to Novo Nordisk for $200 Million

Novavax (NASDAQ: NVX) Sells Czech Manufacturing Facility to Novo Nordisk for $200 Million

December 04, 2024 04:03 AM PST| By Team Kalkine Media

Highlights,Novavax sells Bohumil facility to Novo Nordisk for $200 million, supporting its corporate growth strategy.,Transaction includes $190 million in cash payment in 2024 and $10 million in 2025.,Expected annual operating cost reduction of $80 m...

 Strong Institutional Confidence in Medtronic (NYSE:MDT)

Strong Institutional Confidence in Medtronic (NYSE:MDT)

December 03, 2024 09:15 AM PST| By Team Kalkine Media

Highlights,Edgestream Partners L.P. raised its Medtronic stake by 682.9% in Q3.,Medtronic reported 5.2% revenue growth year-over-year.,Analyst target price upgrades reflect strong confidence in Medtronic's future.,Medtronic plc, has seen significant...

 Encompass Health Co. (NYSE: EHC) Sees Short Interest Increase

Encompass Health Co. (NYSE: EHC) Sees Short Interest Increase

December 03, 2024 08:35 AM PST| By Team Kalkine Media

Highlights,Short interest in Encompass Health Co. increased by 7.8% in November.,Hedge funds and institutional investors hold 97.25% of Encompass Health’s shares.,Encompass Health reported a 11.9% year-over-year revenue growth.,Encompass Health Corp,...

 Exploring the Valuation and Growth of Doximity, Inc. (NYSE:DOCS)

Exploring the Valuation and Growth of Doximity, Inc. (NYSE:DOCS)

December 02, 2024 09:20 AM PST| By Team Kalkine Media

Highlights,Doximity shows recent price growth, but is near fair value.,A strong 31% profit growth forecast over the next two years suggests potential.,High volatility in Doximity's stock could offer future price fluctuation opportunities.,Doximity In...

Recent Articles






Investing Tips

Previous Next